|
Patients who were hospitalized with influenza and were taking a nonsteroidal anti-inflammatory (NSAID) medication had no increased risk of intensive care unit admission or death, according to study results published in JAMA Network Open. During the ongoing coronavirus disease 2019 (COVID-19) pandemic, case reports have described patients without comorbidities developing severe COVID-19 after NSAID use in the early stages of the disease. Therefore, researchers sought to evaluate the potential association of NSAIDs with adverse outcomes in hospitalized patients with influenza or influenza pneumonia.
|